From [HERE] The Telegraph recently reported that the public have been told to stop taking cough and cold medicines over safety fears concerning the drug, pholcodine, an opioid cough suppressant. 

Twenty of the common cough and cold medicines, including Day and Night Nurse capsules, have been urgently withdrawn from the market on the order of the drug regulators because of concerns about a “very rare” risk of anaphylaxis, a life-threatening adverse event. 

The ‘Class 2 Medicines Recall’ announcement taken from the UK government’s website, is shown below. 

When it comes to the mRNA COVID-19 vaccines, the regulatory double standards have never been so glaringly obvious. 

Anaphylaxis was identified as an important risk by the European Medicines Agency, as early as December 2020, in the EMA’s CHMP (Committee for Medicinal Products for Human Use) assessment report on the Pfizer-BioNTech COVID-19 vaccine, seen below. [MORE]